Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells

Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population

(2009) Chun-Shi Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Differential Effect of IL-27 on Developing versus Committed Th17 Cells

(2009) M. El-behi et al.   JOURNAL OF IMMUNOLOGY

IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis

(2009) A. E. Troy et al.   JOURNAL OF IMMUNOLOGY

Interleukin 27: a double-edged sword for offense and defense

(2009) Hiroki Yoshida et al.   JOURNAL OF LEUKOCYTE BIOLOGY

High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD

(2009) Alberto J. León et al.   MEDIATORS OF INFLAMMATION

Interleukin 27 attenuates collagen-induced arthritis

(2008) W Niedbala et al.   ANNALS OF THE RHEUMATIC DISEASES

Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis

(2008) Philip Alex et al.   INFLAMMATORY BOWEL DISEASES

ATP drives lamina propria TH17 cell differentiation

(2008) Koji Atarashi et al.   NATURE